Myopia Management

Global Leader and Partner in Myopia Management

CooperVision is a trusted global leader and partner in myopia management, dedicated to empowering eye care professionals with innovative solutions. Our wide portfolio of myopia management products, including Orthokeratology, Myopia Management Spectacle Lenses, and Daily Disposable Soft Contact lenses offers a comprehensive range of options for eye care practitioners and wearers.

...

Why Myopia Management

Myopia increases the risk of severe ocular health complications and sight-threatening conditions later in life, including retinal detachment, myopic maculopathy, glaucoma, and cataracts.1,2,3,4 Myopia can progress rapidly, particularly in younger children, so it's important to start treatment as soon as possible. 5

...
Event Highlights from APMMS 2023

The Asia-Pacific Myopia Management Symposium (APMMS) serves as a cornerstone event in the realm of myopia research and treatment.

...
Expert Insights from APMMS

Experts decode the best practices of myopia management at APMMS 2023

...
Confronting the Myopia Epidemic: Innovations and Interventions in Asia

With projections indicating that 50% of the world's population will be affected by 2050, urgent action is essential to implement effective myopia control strategies

Reference

  1. Xu L, Wang Y, Wang S, Jonas JB. High myopia and glaucoma susceptibility, the Beijing Eye Study. Ophthalmology. 2007;114(2):216-20.
  2. Flitcroft DI. The complex interactions of retinal, optical and environmental factors in myopia aetiology. Prog Retin Eye Res. 2013;31(6):622-60.
  3. YounanC, et al. Myopia and incident cataract and cataract surgery: the blue mountains eye study. Invest OphthalmolVis Sci. 2002;43(12):3625-3632.
  4. Chen SJ, et al. Prevalence and associated risk factors of myopic maculopathy in elderly Chinese: the Shihpaieye study. Invest OphthalmolVis Sci. 2012;53(8):4868-73.
  5. K. Zadnik , G.L. Mitchell, L.A. Jones, D.O. Mutti ; Factors Associated with Rapid Myopia Progression in School aged Children . Invest. Ophthalmol . Vis. Sci. 2004;45(13):